The Nexeon team is developing and commercializing platforms that address large unmet needs in neurological and cardiovascular diseases. We believe that "smart" devices will enable Doctors to make more effective therapy choices for their patients. These devices will lower costs to the healthcare system, lower the costs to the caregiver and keep a patient in the therapeutic range of the treatment more often.
Our Platform Technology
The thin implantable pulse generator (IPG) provides two connectors for electrode leads with up to 8 contacts each. The heart of the IPG is a custom chip designed to deliver current in multiple contacts independently and simultaneously, making it perfectly suitable for selective electrical stimulation. The chip also incorporates a state-of-the-art recording system to measure evoked potentials, or to monitor stimulation and the system’s integrity.
Capable of independent stimulation of up to 32 connected electrodes
Any conceivable waveform can be programmed; e.g. biphasic pulses, bursts, sine wave, anodal blocking
-t-1497632070774-width-166-name-Nexeon Logo (High res- no background).png "Nexeon Logo (High res, no background)")
-t-1497632070774-width-90-name-Nexeon Logo (High res- no background).png "Nexeon")
Advanced solutions for chronic diseases